IN-DATE
5855200-SD: Bard Power-Trialysis Slim-Cath 12F Straight ST Triple Lumen Dialysis Catheter Max Barrier Tray 20cm
Photos are for illustration purposes only and may not depict the exact item.
Sign in to add this product to your favorites!
| Price: | $59.99 EACH |
|---|---|
| Quantity: | |
| In Stock: | 1 eaches |
| Expiration: | 08-2026 |
Additional Details
BD Bard Power-Trialysis Slim-Cath Short-Term Dialysis Catheter - Max Barrier Tray
- Power-Trialysis Slim-Cath Catheter
- Attachable Suture Wing
- Bouffant Cap
- ChloraPrep Solution One-Step Applicator (2)
- Drape, Full Body 70" x 110"
- Dualator Vessel Dilator 11-13F
- Dualator Vessel Dilator 12-14F
- End Cap (3)
- Filter Straw (2)
- Gauze Pad, 4" x 4" (6)
- Guidewire StruXure™ J-Tip 0.035" x 70cm
- Safety Introducer Needle 18G x 2.75"
- Lidocaine, 1% HCI, 5ml Ampule
- Needle Holder
- Safety Needle, 22G x 1.5"
- Safety Needle, 25G x 0.625"
- Safety Scalpel
- Sodium Chloride (Saline) Solution 0.9% 10ml Ampule
- Suture with Curved Needle
- Syringe, 6ml Luer-Lock
- Syringe, 12ml Luer-Slip
- Transparent Dressing
- Mask (2)
- Gloves, Pair
- Gown
AccessGUDID Info
- FDA Product Code: NIE
- FDA Product Code Name: CATHETER, HEMODIALYSIS, TRIPLE LUMEN, NON-IMPLANTED
- GMDN Term Code: 61629
- GMDN Term Name: Triple-lumen haemodialysis catheter
- GMDN Term Description: A sterile, flexible, triple-lumen tube intended to be used for short-term (< 30 days) central venous (jugular, subclavian vein) and/or femoral vein access to: 1) conduct blood from a patient and return it after extracorporeal circulation, primarily during haemodialysis, but may also be intended for haemoperfusion and/or apheresis; and 2) enable central venous access for intravenous (IV) administration and/or invasive venous blood pressure monitoring. It includes three lumens, two dedicated to coaxial flow of blood for dialysis, and the third intended for independent IV access. Devices dedicated to catheter introduction/function may be included. This is a single-use device.
Manufacturer
C.R. Bard (a part of BD - Becton, Dickinson and Company) was a global leader in the development and manufacturing of innovative medical technologies. Known for their high-quality products, Bard specialized in solutions for vascular access, urology, oncology, and surgical specialties. Their product portfolio included catheters, biopsy devices, implantable ports, and hernia repair systems, designed to enhance patient care and procedural efficiency. As part of BD, the legacy of C.R. Bard continues to drive advancements in healthcare, delivering trusted solutions that improve outcomes for patients and providers worldwide.
